Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (5y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.60 Mn | 143.67 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.35% |
| Dec 31, 2025 | 17.94% |
| Sep 30, 2025 | 82.42% |
| Jun 30, 2025 | 82.93% |
| Mar 31, 2025 | 84.83% |
| Dec 31, 2024 | 3.73% |
| Sep 30, 2024 | 13.32% |
| Jun 30, 2024 | 29.67% |
| Mar 31, 2024 | 7.37% |
| Dec 31, 2023 | 32.79% |
| Sep 30, 2023 | 11.99% |
| Jun 30, 2023 | -244.08% |
| Mar 31, 2023 | 14.87% |
| Dec 31, 2022 | 258.82% |
| Sep 30, 2022 | 18.55% |
| Jun 30, 2022 | 10.29% |
| Mar 31, 2022 | 7.12% |
| Dec 31, 2021 | -404.28% |
| Sep 30, 2021 | -17.58% |
| Jun 30, 2021 | -1.99% |